What is MoldCo?
MoldCo is a health technology company focused on providing comprehensive solutions for mold-related health issues. Their offerings include specialized biomarker testing, research-backed binders, nasal biofilm disruptors, and peptides. The company distinguishes itself through its team of mold-trained and certified clinicians who guide its 100% online service delivery model. This approach aims to address a critical unmet need in environmental health and personalized medicine.
How much funding has MoldCo raised?
MoldCo has raised a total of $3M across 1 funding round:
Other Financing Round
$3M
Other Financing Round (2024): $3M with participation from Bleu Capital, Starship Ventures, and Night Ventures
Key Investors in MoldCo
Bleu Capital
Bleu Capital is a venture family office that invests in climate companies, likely bringing strategic expertise in early-stage funding and sustainable growth to MoldCo.
Starship Ventures
Starship Ventures, a firm backing contrarian deep tech founders, may offer MoldCo insights into advanced materials and scientific innovation relevant to their biomarker and peptide research.
Night Ventures
Night Ventures, operating within the restaurant industry, suggests a diverse investment portfolio, potentially offering unique market perspectives or operational support to MoldCo.
What's next for MoldCo?
The recent major strategic investment positions MoldCo for significant expansion and further development of its innovative diagnostic and therapeutic tools. With a focus on research-supported solutions and expert clinical guidance, the company is poised to scale its operations and reach a broader market. This capital will likely fuel advancements in biomarker identification, peptide therapies, and the enhancement of their online platform, solidifying their role as a leader in mold-focused health.
See full MoldCo company page
